Start here
Beginner literacy
Concepts that help readers parse peptide claims. Not dosing. Not sourcing. Not stacks-as-instructions.
Literacy shelf
Three places to begin
Start with definitions, then vocabulary, then how we weigh online stories.
Four reading lenses: Read the source · Weigh the layers · Track the timeline · Build the habit
What is a peptide?
A plain-language definition, and why the word alone settles nothing about approval or safety.
Free beginner glossary
Shared vocabulary for reading study language and headlines without the hype.
How we assess online stories
Three questions on every claim: what the source reports, what remains uncertain, where to check it.
Literacy shelf
Three places to begin
Start with definitions, then vocabulary, then how we weigh online stories.
Four reading lenses: Read the source · Weigh the layers · Track the timeline · Build the habit
What is a peptide?
A plain-language definition, and why the word alone settles nothing about approval or safety.
Free beginner glossary
Shared vocabulary for reading study language and headlines without the hype.
How we assess online stories
Three questions on every claim: what the source reports, what remains uncertain, where to check it.
Basics
What is a peptide?
A peptide is a short chain of amino acids — the same building blocks that make up proteins, just shorter. Many medicines people already know are peptides or peptide-related; the word alone does not tell you whether a substance is FDA-approved, safe, effective, or legal to compound.
Therapeutic peptide research has deep roots. Insulin — a 51–amino-acid peptide hormone — was isolated in 1921 and entered clinical use in 1922; it is widely treated as the first modern peptide medicine (see FDA’s 100 Years of Insulin history exhibit). Later decades added many more peptide and peptide-analog drugs. Today’s research notes often mix approved peptide medicines, investigational trial drugs, compounded preparations, and research-chemical catalog items — Peptide Straight Talk keeps those objects separate.
Peptide or protein? Where regulators draw the line
In 2020, FDA finalized a bright-line definition: a protein is an alpha amino acid polymer with a specific defined sequence that is greater than 40 amino acids in size (21 C.F.R. §600.3(h)(6)). FDA’s draft peptide clinical-pharmacology guidance uses the complementary shorthand: for that guidance, a “peptide” is 40 or fewer amino acids and — if it meets the drug definition and not the biologic definition — is regulated as a drug. More in our Sep 24 flash →
Educational only. Not medical advice. No dosing, sourcing, or protocols.
Free basics
Beginner glossary
New to the abbreviations and source labels? Start with our free beginner reference — plain-language “means / does not mean” for the tags we use in briefings.
Peptide — A short chain of amino acids (the building blocks of proteins). Many medicines and research compounds are peptides or peptide-related; the word alone does not tell you whether something is approved, safe, or effective.
We spell out each abbreviation when it first appears in an issue, then use the short form. For example: randomized controlled trial (RCT).
How we assess claims
Three questions on every claim
What does the study or source report?
We explain what was reported, how the research was done, and whether we are reading a journal article, registry record, company announcement, conference material or agency statement.
What remains uncertain?
We explain what the source leaves unanswered. A trial marked completed or a result announced at a conference does not by itself mean a full research paper has been published or peer review is confirmed.
Where can readers check the original source?
We link to the original documents so readers can check the wording and context themselves.
See it applied in Issue #1: we assess claims, not people.